0001070081-19-000009.txt : 20190109 0001070081-19-000009.hdr.sgml : 20190109 20190109170930 ACCESSION NUMBER: 0001070081-19-000009 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190107 FILED AS OF DATE: 20190109 DATE AS OF CHANGE: 20190109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Peltz Stuart Walter CENTRAL INDEX KEY: 0001578962 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35969 FILM NUMBER: 19518750 MAIL ADDRESS: STREET 1: PTC THERAPEUTICS, INC. STREET 2: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PTC THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001070081 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043416587 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080-2449 BUSINESS PHONE: 9082227000 MAIL ADDRESS: STREET 1: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080-2449 FORMER COMPANY: FORMER CONFORMED NAME: PTC THERAPEUTICS INC DATE OF NAME CHANGE: 19980909 4 1 wf-form4_154707175413809.xml FORM 4 X0306 4 2019-01-07 0 0001070081 PTC THERAPEUTICS, INC. PTCT 0001578962 Peltz Stuart Walter C/O PTC THERAPEUTICS, INC. 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080 1 1 0 0 Chief Executive Officer Common Stock 2019-01-07 4 S 0 1764 34.75 D 24882 D Common Stock 2019-01-07 4 S 0 339 34.75 D 17947 I By Spouse Common Stock 2019-01-07 4 S 0 409 34.75 D 17538 I By Spouse Stock Option (Right To Buy) 451.2 2019-05-15 Common Stock 41.0 41 I By Spouse Stock Option (Right To Buy) 1149.6 2020-02-02 Common Stock 37.0 37 I By Spouse Stock Option (Right To Buy) 490.8 2021-04-27 Common Stock 58.0 58 I By Spouse Stock Option (Right To Buy) 218.4 2022-01-10 Common Stock 38.0 38 I By Spouse Stock Option (Right To Buy) 10.85 2023-05-15 Common Stock 3900.0 3900 I By Spouse Stock Option (Right To Buy) 27.05 2024-01-28 Common Stock 4900.0 4900 I By Spouse Stock Option (Right To Buy) 51.0 2025-01-02 Common Stock 10880.0 10880 I By Spouse Stock Option (Right To Buy) 30.86 2026-01-03 Common Stock 11000.0 11000 I By Spouse Stock Option (Right To Buy) 12.64 2026-11-16 Common Stock 2000.0 2000 I By Spouse Stock Option (Right To Buy) 11.23 2027-01-02 Common Stock 12600.0 12600 I By Spouse Stock Option (Right To Buy) 18.01 2028-01-02 Common Stock 30625.0 30625 I By Spouse Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 5,400 shares of restricted stock from a January 3, 2017 grant of 21,600 shares of restricted stock. Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 975 RSUs from a January 3, 2017 grant of 3,900 RSUs. Includes: 1) 1,950 unvested RSUs from an award of 3,900 RSUs granted on January 3, 2017, which vests in four equal annual installments over four years, commencing on January 3, 2018; and 2) 5,250 shares of restricted stock granted on January 3, 2018, which vest in four equal annual installments over four years, commencing on January 3, 2019. The reporting person acquired beneficial ownership of these securities upon his marriage to the owner of the securities in 2018. Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 1,312 shares of restricted stock from a January 3, 2018 grant of 5,250 shares of restricted stock. Currently exercisable. This option was granted on January 4, 2016, and vests over four years, with 25% of the shares underlying the option vesting on January 4, 2017, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 4, 2017. This option was granted on November 17, 2016 and vests over four years, with 25% of the shares underlying the option vesting on November 17, 2017, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on February 17, 2018. This option was granted on January 3, 2017, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2018, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2018. This option was granted on January 3, 2018, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2019, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2019. /s/ Avraham S. Adler, attorney-in-fact 2019-01-09